Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-1532
Full Text
Open PDFAbstract
Available in full text
Date
October 9, 2012
Authors
Publisher
American Association for Cancer Research (AACR)